Cells in biological systems require constant and highly regulated movement of ions across cell membranes, to perform or regulate virtually all biological processes. Rapidly gating (opening and closing) voltage-gated sodium channels and potassium channels generate and propagate the action potentials required for nervous signaling, the heartbeat and other processes in excitable cells [1] [2] [3] . An array of calcium channels, including voltage-gated and store-operated channels on the plasma membrane, and channels in the sarcoplasmic/ endoplasmic reticulum membrane that are opened by a variety of stimuli including Ca 2+ and coupling to plasma membrane Ca 2+ channels, increase cytosolic Ca 2+ levels to trigger processes as diverse as wound healing, fertilization, gene transcription, immune responses, and long-term potentiation [4] [5] [6] [7] [8] [9] . Other classes of ion channels with various grades of ion selectivity are required for ion and fluid homeostasis and secretion, regulation of resting membrane potential, and hormone production and secretion, often in nonexcitable cells such as polarized epithelial cells [10] [11] [12] [13] [14] .
Ion channels do not actively transport ions, but instead they facilitate ion diffusion down an electrochemical gradient, by creating an aqueous pathway through otherwise inhospitable cell membranes. These pathways are typically selective either for specific ions or classes of ions, and diffusion is highly regulated. This regulation often takes the form of gates intrinsic to the channel protein, which open and close to permit or stem ion flow; other forms of regulation can involve extrinsic moieties, for example, inward rectification of some ion channels via block by Mg 2+ and other molecules at depolarized voltages. Most ion channels, in addition to opening (activation) and closing (deactivation) also have an inactivation or desensitization gate Abbreviations ABC, ATP-binding cassette; CFTR, cystic fibrosis transmembrane conductance regulator; CSF, cerebrospinal fluid; ENaC, epithelial sodium channel; NCC, sodium chloride cotransporter; NIS, sodium iodide symporter; PIP 2 , phosphatidylinositol 4,5-bisphosphate; PI, phosphatidyl inositol; SGLT1, sodium-dependent glucose transporter 1; SMIT1, sodium-dependent myo-inositol transporter 1; SMIT2, sodium-dependent myo-inositol transporter 2; SPCA2, secretory pathway Ca 2+ -ATPase isoform 2; STIM1, stromal interaction molecule 1; SUR, sulfonylurea receptor.
that can close to stem the flow of ions even when the activating stimulus (e.g., membrane depolarization, ligand binding) is still present [15] [16] [17] [18] . Another type of protein termed a uniporter, distinct from channels, also mediates movement of solutes across the cell membrane down their concentration gradient, but instead works by facilitative diffusion. Thus, solutes bind to, for example, the extracellular side of the protein, which then changes conformation to expose the bound solute to the intracellular side, permitting diffusion into the cell. Examples include the facilitated glucose transporters GLUT1-4 [19, 20] .
In contrast, many other classes of transporters move solutes across membranes up their concentration gradient. This is achieved via one of various mechanisms. Secondary active transporters utilize a downhill ionic gradient, to move a solute up its concentration gradient concomitant with downhill transport of the ion [21] [22] [23] . For example, SGLT1 utilizes a downhill Na + gradient to move glucose into cells, up its concentration gradient. Sodium-coupled transporters represent a major class of secondary active transporters for a range of ions and solutes, and several will be covered in this review. They are termed 'secondary' active transporters because energy from ATP hydrolysis is required to establish the Na + gradient they require for function, but the hydrolysis is not performed by the sodium-coupled transporter itself [24, 25] . Instead, the Na + gradient is established by another protein, such as the Na + /K + -ATPase, which is often described as pump. The Na + /K + -ATPase is a primary active transporter because it hydrolyzes ATP to provide energy to pump K + into the cell and Na + out of the cell, both against their electrochemical gradients [26] .
For many cellular processes, ion channels must work in concert with ion and solute transporters. The Na ATPase for nervous signaling is amply illustrated by the calculation that this one type of pump protein accounts for as much as two-thirds of neuronal energy expenditure [36] .
By the same token, solute transporters, including pumps, may be reliant upon ion channels. As Beyond functional cooperation between ion channels and transporters, some channels have been found to form physical complexes with solute transporters, a phenomenon that has not yet been described for H + /K + -ATPase or Na + /K + -ATPase. Novel channel-transporter (chansporter) complexes are being discovered more frequently in the last 5 years than ever before, suggesting they may represent a previously overlooked, yet important mode of cellular signaling. In this review, the author describes examples of chansporter complexes reported in the literature, together with their known or suspected physiological roles and the types of signal integration they facilitate. The complexes covered in this review are summarized in Table 1. SLC5A sodium-coupled solute transporter interactions with KCNQ potassium channels
Voltage-gated potassium (Kv) channels are formed by pore-forming a subunits that coassemble into tetramers around an aqueous ion-conducting pore. They are in general highly selective (>10 : 1) for K + over Na + , a property important for their role in repolarizing excitable cells to end each action potential. Kv channel a subunits are encoded by 40 different genes in the human genome, each of which fall into one of 12 (depending on which nomenclature is used) subfamilies. Most Kv a subunits are functional as homomers, but many form heteromers with other a subunits (typically but not always from the same subfamily) that display distinct functional characteristics and may be prerequisite for some biological processes [2] .
Most if not all Kv a subunits also coassemble with some form of ancillary or b subunit to facilitate their surface trafficking or targeting, and/or modify their function for specific biological activities [51-54]. Still others, termed 'silent' a subunits, either silence other a subunits upon heterotetramerization, or require heteromerization with other a subunit types for ion conduction [55, 56] . Kv a subunits, including silent a subunits, each possess six transmembrane domains split into a voltage-sensing domain (VSD; transmembrane helices S1-S4) and a pore module (S5 and S6) [57] [58] [59] (Fig. 1A) . Kv channel ancillary subunits can be single transmembrane-spanning (1TM) such as the KCNEs (Fig. 1A) or entirely cytosolic and their importance to normal channel function in vivo is emphasized by the pathogenic effects of their disruption [60] [61] [62] [63] [64] [65] .
The Kv a subunits in the KCNQ (Kv7) subfamily are represented by five isoforms in the human genome, KCNQ1-5. KCNQ channels are notable for their slow gating kinetics, small and flickery unitary conductance, and relatively little inactivation. KCNQ1 is a ubiquitous channel which is both important for human cardiomyocyte repolarization, and prominent in the essential functions of many different types of nonexcitable, polarized epithelial cells. These contrasting roles are made possible by interaction of KCNQ1 with a variety of b subunits, most notably the KCNE 1TM subunits [66] .
Each of the five KCNE isoforms coassembles with and regulates KCNQ1 with divergent functional outcomes. For example, KCNE1 slows KCNQ1 activation 5-10-fold, positively shifts KCNQ1 voltage dependence of activation such that more comprehensive membrane depolarization is required for channel activation (Fig. 1A) , removes inactivation [67] [68] [69] [70] , and increases sensitivity 100-fold to current potentiation by phosphatidylinositol 4,5-biphosphate (PIP 2 ) [71] . PIP 2 is a minor membrane phospholipid constituent that plays a major role in regulating membrane excitability by binding to and regulating the gating of many different ion channels [72] [73] [74] , and features heavily in the discussions below. KCNE1 slows KCNQ1 activation by a mechanism involving probably both the transmembrane domain and C-terminal domain of KCNE1. One school of thought is that KCNE1 slows down movement of the charged, voltage-sensing S4 segment of KCNQ1 to slow its activation, possibly also involving regulation of how S4 interacts with S5, and formation of a stable preopen state [75] [76] [77] [78] ; another school of thought is that in addition to S4 slowing, KCNQ1-KCNE1 channels require all four voltage sensors to activate before channel opening, while KCNQ1 activation without KCNE1 requires only one voltage sensor to move [79, 80] . KCNQ1-KCNE1 channels generate the slowly activating potassium current (I Ks ) that is important for cardiomyocyte repolarization, and also form a channel required for endolymph secretion in the inner ear. Hence, individuals with severe loss-offunction mutations, typically in both alleles, suffer from the cardioauditory Jervell and Lange-Nielsen syndrome, which presents as Long QT Syndrome (delayed ventricular repolarization) and congenital profound bilateral sensorineural hearing loss [39, [81] [82] [83] . KCNQ1 requires coassembly with calmodulin for surface expression and normal function (Fig. 1B) . KCNE1 is thought to fit into a pocket between the VSD of one KCNQ1 subunit and the pore module of another, within I Ks channel complexes (Fig. 1C) . It is likely that other KCNEs are similarly localized. Two KCNE1 subunits are thought to exist in each functional I Ks complex with four KCNQ1 a subunits (Fig. 1C ) although some suggest this can be variable and rise to 4 : 4 stoichiometry [84] [85] [86] [87] [88] . In contrast, as mentioned above, KCNQ1-KCNE2 (and KCNQ1-KCNE3; Fig. 1A ) channels are constitutively active, and also noninactivating, meaning that they can provide a constant repolarizing force when cells are positive to the potassium equilibrium potential (E K ), which is typically around À80 mV under physiological conditions. Thus, in polarized epithelial cells, which often remain at potentials between À40 mV and À20 mV, KCNQ1-KCNE2 can facilitate steady K + efflux unless closed by other forms of regulation [40, 42, 43, 89] . KCNQ1-KCNE2 channels are required for gastric acid secretion (as explained above) and also for optimal thyroid hormone secretion; genetic deletion of either protein causes hypothyroidism [90] [91] [92] . KCNQ1 and KCNE2 are also expressed in pancreatic b cells, where they may also form a heteromeric channel complex. Germline deletion of Kcnq1 increases glucose tolerance in mice [93] , whereas deletion of Kcne2 decreases glucose tolerance, decreases insulin sensitivity, and impairs insulin secretion in response to glucose [94, 95] . This hints at the complex effects of KCNE2 on KCNQ1: the channel is converted to a constitutively active one, but the channel outward current is decreased (possibly by reduced surface expression and/or other mechanisms). Thus, KCNE2 coassembly has opposite effects on KCNQ1 current magnitude depending on the membrane potential at which is it measured [89] . KCNE2 appears to be most highly expressed in the choroid plexus epithelium, where it regulates KCNQ1 and also the Kv1.3 (KCNA3) potassium channel on the apical side [96] .
The KCNQ1-KCNE3 channels are also constitutively activated and have been mechanistically studied more than KCNQ1-KCNE2, largely because they generate more robust currents, making it easier to study effects of mutagenesis, etc. We and others have shown that KCNE3 locks open the KCNQ1 VSD, via residues including V72 in the transmembrane segment and D54 and D55 in the KCNE3 N-terminal segment [97-104]. KCNQ1-KCNE3 generates a K + current important for regulating cAMP-stimulated chloride secretion in the intestine [105] . KCNE4 and KCNE5, in contrast, each inhibit KCNQ1 activity; in the case of KCNE4 this effect involves calmodulin but probably not impaired trafficking [106] [107] [108] , while the KCNE5 effect involves a positive shift in the voltage dependence of activation [109] . For detailed reviews of KCNE family regulation of KCNQ1 and other a subunits, see [63] [64] [65] [66] .
KCNQ1 interaction with sodium-coupled myoinositol transporters
The choroid plexus epithelium is the primary site for cerebrospinal fluid (CSF) production and secretion; deletion of KCNE2 depolarizes choroid epithelial cells, alters their cellular Kv currents, increases seizure susceptibility, and decreases immobile time in the tail suspension test-both of the latter suggesting increased neuronal excitability. Metabolomics analysis revealed that KCNE2 deletion in mice decreases CSF levels of the major osmolyte, myo-inositol, by~30%. Megadosing with myo-inositol by intraperitoneal injections restored normal seizure susceptibility and tail suspension behavior in Kcne2 À/À mice without affecting wild-type mice, suggesting a causative role for altered myo-inositol handling in the neural defects in Kcne2 À/À mice [96, 110] . Accordingly, KCNQ1-KCNE2 channels were found to form physical complexes with the sodium-coupled myo-inositol transporter, SMIT1 (encoded by SLC5A3), in mouse choroid plexus and when heterologously coexpressed in Chinese Hamster ovary (CHO) cells [110] . SMIT1 is predicted to be ã 14-transmembrane segment protein ( Fig. 2A) , closely related to the sodium-coupled glucose transporter, SGLT1 [25,111-113], but favoring myo-inositol versus glucose as a substrate.
Myo-inositol performs a variety of crucial cellular functions aside from its osmoregulatory properties. Myo-inositol is converted to phosphatidylinositol (PI) and phosphatidylinositol 4,5-biphosphate (PIP 2 ) by phosphatidylinositol 4-kinase (PI4K) and phosphatidylinositol 5-kinase (PI5K). PIP 2 is a prerequisite for normal functioning of many ion channels (e.g., KCNQs, inward rectifier K + channels, transient receptor potential (TRP) channels and ryanodine receptors), transporters (e.g., sodium/hydrogen exchangers), and pumps (e.g., plasmalemmal calcium pumps) [72] [73] [74] . In addition, Gq-coupled receptor stimulation activates phospholipase C (PLC), cleaving PIP 2 into inositol (1,4,5)-triposphate (IP 3 ), and diacylglycerol (DAG) (Fig. 2B) , each of which contributes to protein kinase C (PKC) activation and subsequent downstream signaling cascades. IP 3 also activates IP 3 receptors, releasing Ca 2+ from intracellular stores such as the endoplasmic reticulum.
While KCNQ1 coexpression enhanced SMIT1 myoinositol uptake, KCNQ1-KCNE2 inhibited it, as did coexpression with R231A-KCNQ1, a constitutively active mutant with the VSD locked in the active state [110] . This suggests a more complicated chansporter relationship than merely Kv channel cellular hyperpolarization increasing the electrical gradient to enhance Na + -coupled myo-inositol influx, as R231A-KCNQ1 would be predicted to serve this role very efficiently. R231A-KCNQ1 also inhibited activity of SMIT2, a SMIT1-related myo-inositol transporter encoded by SLC5A11, while SMIT2 inhibited KCNQ1 activity, when the two were coexpressed in Xenopus oocytes [110] .
Later work showed that SMIT2 regulates KCNQ channels in mammalian and Drosophila neurons (see below). Furthermore, the closely related KCNQ4 channel did not augment or otherwise alter SMIT1 activity when coexpressed in oocytes, also suggesting against solely the hyperpolarizing effects of KCNQ1 as being important for SMIT1 regulation. However, it appears that KCNQ1 pore activity is important for this role, as inhibiting with KCNQ channel blocker XE991 also inhibited coexpressed SMIT1 activity [110] . The author's lab is currently investigating how SMIT1 coexpression alters KCNQ1 channel functional properties and pharmacology. Initial findings suggest intimate association of SMIT1 with the KCNQ1 channel pore module. Thus, SMIT1 coexpression, in the absence of extracellular myo-inositol or other SMIT1 [190] and SLC26Dg (a representative of the SLC26 transporters) [191] . Substrates (magenta) shown in binding sites. (B) In this and subsequent panels, high-resolution structures obtained by X-ray crystallography or cryo-EM are shown for proteins known to participate in chansporter complexes, or structures of their closest relatives for which high-resolution structural information is available. Unless otherwise stated, coloring progresses from (red to blue) N-terminal to C-terminal highlighting individual secondary structural elements such as individual transmembrane helices. This panel: Xenopus KCNQ1 with calmodulin bound [186] represents KCNQ1, 2, 3, or 4; vSGLT [190] is in place of SMIT1 or 2; Deinococcus geothermalis SLC26 [191] is in place of prestin. Red arrows indicate known or putative ('?') direct physical interaction. Green lines approximate membrane boundaries. Also shown is the myo-inositol (MI) pathway, indicating how SMIT-transported myo-inositol can generate PIP 2 which then regulates KCNQ gating. Abbreviations: PI4K, phosphatidylinositol 4-kinase; PI5K, phosphatidylinositol 5-kinase; PLC, phospholipase C; DAG, diacylglycerol; IP 3 , inositol ( substrates, changes ion selectivity, voltage dependence, and pharmacology of KCNQ1 in a KCNE1-dependent manner, consistent with a model in which SMIT1 physically interacts with the KCNQ1 pore or close enough to it to alter its fundamental attributes. This association may include altering the way in which KCNE1 modulates KCNQ1, or even competition between SMIT1 and KCNE1 for interacting with similar sites in the KCNQ1 pore or gating apparatus [114] .
One could speculate that transporters such as SMIT1 might interact one per KCNQ1 tetramer, potentially leaving room for other types of transporter to coassemble as well (Fig. 2C ), or 4 : 4 giving an octameric complexes with the tetramer of KCNQ1 a subunits (Fig. 2D) .
The KCNQ1-KCNE2 channels also functionally interact with the sodium/iodide symporter (NIS; encoded by SLC5A5), a close relative of SMIT1. Germline deletion of either Kcnq1 or Kcne2 in mice causes hypothyroidism, and KCNQ1-KCNE2 channels are required for optimal thyroid cell iodide uptake by NIS, for thyroid hormone production [90, 92] . The mechanisms by which KCNQ1-KCNE2 regulates NIS have yet to be fully established.
KCNQ2/3 interaction with myo-inositol transporters
While KCNQ1 is synonymous with human ventricular repolarization and roles in various secretory epithelia, the remainder of the KCNQ family members (2-5) are better known for generating the muscarinic-inhibited (M) current in mammalian neurons [115] [116] [117] [118] [119] . KCNQ2 and KCNQ3 in particular are expressed widely in the brain, where they form heteromeric Kv channels in axon initial segments (AIS) of neurons. In addition, KCNQ2 and KCNQ3 form channels alone or with one another in nodes of Ranvier in nerves including the sciatic nerve [120] [121] [122] [123] . KCNQ2/3 channels act as gatekeepers, controlling neuronal excitability by raising the threshold for action potential firing. Upon activation of the muscarinic acetylcholine receptor, KCNQ2/ 3 channels are inhibited, depolarizing the cell sufficiently to initiate an action potential [121] .
As was also found for KCNQ1 channels, KCNQ2/3 channels are regulated by PIP 2 , which negatively shifts their voltage dependence such that they activate at more hyperpolarized membrane potentials, further quelling membrane excitability [73, [124] [125] [126] [127] [128] . Aside from being an important osmolyte, myo-inositol is a substrate for PIP 2 , and therefore SMIT1 can increase cellular PIP 2 content by transporting myo-inositol into the cell. Dai and colleagues showed that this is one mechanism by which neuronal electrical activity can be linked to extracellular osmotic changes: increased extracellular myoinositol is transported into the cell by SMIT1, raising PIP 2 levels, negatively shifting the voltage dependence of KCNQ2/3 channel activation, hyperpolarizing the cell, and reducing cellular excitability [129] .
We found that not only is SMIT1-transported myoinositol able to generate sufficient PIP 2 to modulate KCNQ2/3 activity, as reported by Dai et al. but also that SMIT1 forms physical complexes with KCNQ2, and that KCNQ2 and KCNQ3 each colocalize with SMIT1 and/or SMIT2 in axon initial segments and sciatic nerve nodes of Ranvier [130] . Colocalization/ coassembly of KCNQ2/3 channels with SMIT1/2 may facilitate the channel being able exploit locally high PIP 2 concentrations generated from SMIT1/2-transported myo-inositol, an hypothesis supported by previous studies showing that PIP 2 diffusion is quite slow in the presence of intact cytoskeleton [131] , and our finding that disruption of the cytoskeleton impairs the ability of SMIT1 to potentiate KCNQ2/3 current after 3 h of incubation in 1 mM myo-inositol [130] . Reciprocally, KCNQ2/3 channels protect SMIT1 activity from the otherwise inhibitory effect of cellular depolarization via high extracellular K + [130] . In tight confines such as axons, where diffusion might be slower for some molecules than in the soma, close physical proximity between KCNQ2/3 and SMITs could be particularly advantageous, but what other advantages might KCNQ2/3-SMIT1/2 coassembly confer? Ongoing work in the author's laboratory suggests that SMIT1 binds directly to the KCNQ2 pore module, and in the absence of myoinositol, SMIT1 binding itself alters KCNQ2/3 ion selectivity, gating, and pharmacology, indicative of direct influence on pore architecture and fundamental channel properties [114]. Thus, SMIT-KCNQ coregulation probably involves both direct physical contact and regulation by myo-inositol-derived PIP 2 (Fig. 2B) .
The physiological significance in vivo of the regulatory modes described above remains to be determined. However, there is a striking similarity between the phenotypes of mice with either Kcnq2 or Slc5a3 (SMIT1) germline-deleted: disruption of either gene causes death within hours after birth from hypoventilation [132, 133] . Likewise, some human KCNQ2 sequence variants also cause respiratory dysfunction [134] . In Slc5a3À/À mice, this phenotype can be avoided by supplementing the drinking water of the dam during gestation and lactation with 1 mM myo-inositol. Thus, the myo-inositol transported into phrenic nerves by SMIT1 is required for normal development and function of peripheral nerves, and for innervation of the diaphragm and ventilation [135] . An interesting experiment would be to similarly try to rescue Kcnq2À/À mice using myo-inositol, but this may not work, as just having myo-inositol, but not the channel that the PIP 2 it generates presumably regulates in phrenic nerves (KCNQ2), may not suffice. Nevertheless, the phenotypic similarity of the two mouse lines, and the KCNQ2/3-SMIT1/2 colocalization we observed in sciatic nerve, are highly suggestive of requisite cooperation and chansporter complex formation in vivo. Unlike other family members, KCNQ4 and KCNQ5 have not yet been found to interact with SLC5A family transporters, but KCNQ4 is suggested to interact with SLC26A5 (Prestin) (see below).
dKCNQ interaction with cupcake
Vinegar flies (Drosophila melanogaster) express an ortholog of mammalian SMIT2 (gene name SLC5A11 in either case), termed cupcake [136] . Deletion of SLC5A11 renders Drosophila insensitive to the nutritional value of sugars. Cupcake is required for the increased excitability of ellipsoid body R4 neurons observed during fly starvation, which normally drives feeding and other hunger-driven behaviors. Cupcake expression in the brain, accordingly, is increased during starvation and decreased shortly after feeding of starved flies. It appears, however, that cupcake is not a sugar transporter, but rather it may act as a sugar sensor. Thus, unlike related mammalian transporters such as SGLT1, cupcake lacks a consensus sugar-binding site. Cupcake does not generate glucose-dependent currents when it is studied in Xenopus oocytes, although it does pass a large constitutive current that requires sodium and a conserved sodium-binding site [136, 137] . However, as described for mammalian SMITs above, cupcake coassembles with dKCNQ, a Drosophila Kv channel orthologous to mammalian KCNQs. Cupcake coassembly inhibits dKCNQ (as we previously found for the mammalian cupcake ortholog, SMIT2, with KCNQ1 [110]), and dKCNQ is required for normal feeding behavior and food selection by controlling the excitability of neurons expressing cupcake [137] .
SLC26A family anion transporter interactions with ion channels
Prestin interaction with KCNQ channels KCNQ4 is a Kv channel a subunit structurally and functionally closely related to KCNQ2, 3, and 5. KCNQ4 is distinguished from these other KCNQ family members primarily by its expression in mammalian cochlea and auditory neurons, and its association when disrupted with human and mouse hearing loss. KCNQ4 is required for normal cochlear ion homeostasis and inherited sequence variants in KCNQ4 cause DFNA2, which presents as progressive sensorineural hearing loss at all frequencies [138] . Many of the KCNQ4 DFNA-linked mutations impair KCNQ4 trafficking to the plasma membrane and/or impair channel conductance when at the membrane [139, 140] .
Prestin (encoded by SLC26A5) is part of the SLC26 family of anion transporters that also includes pendrin (encoded by SLC26A4) (Fig. 2A) . While pendrin is a more conventional, sodium-independent, electroneutral chloride/iodide transporter (anion exchanger), prestin is a motor protein in addition to being an anion transporter. Mechanical elongation and contraction of prestin underlies electromotility of outer hair cells of the inner ear, important for the amplification of sound waves that is required for high sensitivity hearing [141, 142] . Prestin is thought to be intrinsically voltagesensitive by virtue of the ability to change shape in response to binding of intracellular chloride ions. Independent of this voltage sensing, prestin is also thought to have the capacity to transport anions, although was unable to do so when heterologously expressed in Xenopus oocytes, suggesting the possibility that oocytes lack an essential component required for the transport function of prestin [143] [144] [145] [146] [147] .
Like KCNQ4, inherited sequence variants in SLC26A5, the gene encoding prestin, cause nonsyndromic hearing loss [148, 149] . It is therefore very interesting that prestin expressed in CHO cells shifted left the voltage dependence of activation of coexpressed KCNQ4, by about -15 mV; pendrin coexpression, in contrast, did not affect KCNQ4 activation. A similar -15 mV shift in the voltage dependence of activation was found when KCNQ2/3 channels were coexpressed with prestin, but a lesser effect (-5 mV) was observed when prestin was coexpressed with Kv1.1 (KCNA1) [150] . It is not yet known whether the functional effects of prestin on KCNQ channels arise from direct physical interaction (Fig. 2B,C) , nor whether the interaction occurs in native outer hair cells.
SLC26A chloride and bicarbonate exchanger interaction with CFTR
Prestin, pendrin, and also related SLC26 chloride and bicarbonate exchanger family members A2 and A3, form complexes with another ion channel-the cystic fibrosis transmembrane conductance regulator (CFTR) [151] . CFTR is a highly unusual protein that displays not only some functional properties of a chloride channel but also those of an ATP-binding cassette ABC transporter; while most ABC transporters operate by active transport, CFTR is a Cl À channel through which Cl À passes by diffusion [152, 153] .
SLC26Ax-CFTR complexes are thought to form in, for example, the pancreas and salivary glands, where the native epithelial chloride absorption and bicarbonate secretion characteristics are more similar to those of the complexes than of CFTR alone; dysfunction of the complexes may contribute to diseases including cystic fibrosis and congenital chloride diarrhea [154, 155] . Thus, CFTR mutations cause cystic fibrosis [156] [157] [158] ; SLC26A2, A3, and A4 mutations cause diastrophic dysplasia [159] , congenital chloride-losing diarrhea [160] , and Pendred syndrome (deafness, goiter, and organification defects) [161] , respectively. The molecular basis of SLC26A-CFTR interaction has been well studied. The STAS domain of some SLC26A transporters has been found to mediate interaction with CFTR via the phosphorylation site-rich R domain of the latter, assisted by PDZ ligand-mediated binding of both proteins to scaffolding proteins such as CAP70 (Fig. 3A) . When nonphosphorylated, the CFTR R domain binds to CFTR NBD1 to stop it interacting with NBD2, which would result in CFTR Cl-channel activity. The SLC26A STAS domain stabilizes this autoinhibition. When phosphorylated by PKA, R domain-NBD1 interaction is altered and R domain-STAS domain binding is enhanced-this activates both CFTR and SLC26A anion transport leading to fluid and electrolyte secretion [152, 154, 162, 163] . The isolated STAS domain from SLC26A3 potentiates CFTR open probability (P o ) >threefold, and the number of active channels (n) 9 channel open probability (nP o ) sixfold, while leaving total surface CFTR protein levels unaffected. Similarly, CFTR coassembly potentiates SLC26A6 activity [154, 155] . There, is, however, further complexity to STAS-CFTR interactions-for SLC26A3 or SLC26A6 this interaction results in reciprocal potentiation, but in the case of SLC26A9, CFTR is activated but SLC26A9 is inhibited by the interaction [164, 165] .
ABC and ATPase interactions with ion channels

Sulfonylurea receptor interactions with ion channels
Sulfonylurea receptors (SURs) are integral membrane proteins that hydrolyze ATP. SURs are members of the ABC superfamily of active transporters, but unlike the majority of family members, SURs are neither active transporters, nor do they even pass ions themselves (unlike CFTR). Instead, SURs are best known for acting as regulatory subunits for K ATP channels, which comprise an octamer of four SURs (Sur1 or 2) and four Kir6.1 or Kir6.2 a subunits (Fig. 3B,C) . K ATP channels act as metabolic sensors in tissues including the pancreas and heart; ATP binding to the Kir6.x subunits closes the channel, MgATP binding to SURs counteracts this by inducing a conformational change in the channel [166] . It is interesting, therefore, to view K ATP channels as another example of chansporter complexes, albeit the 'transporter' belongs to a transporter family without actually transporting anything. The theme of the 'transporter' in a chansporter complex not actually transporting anything when in the complex appears to also apply to the Drosophila cupcake (encoded by SLC5A11) protein related to mammalian SMIT2 (also encoded by SLC5A11) (see above).
Sulfonylurea receptor 1 also participates in another type of channel complex, with TRPM4, a calcium-activated monovalent cation-nonselective channel ( Fig. 3B ). SUR1/TRPM4 channels are not expressed under normal physiological conditions, but are upregulated in neurons, astrocytes and capillary endothelial cells following various types of brain or spinal cord injury, and are thus important mediators of cerebral edema formation. Coassembly with SUR1 renders TRPM4 channel activity sensitive to drugs that bind to SUR1, including inhibitors glibenclamide and tolbutamaide, and activator diazoxide [167] . TRPM4/SUR1 channels only activate after ATP depletion [168] . As is observed for K ATP channels, one could speculate a 4 : 4 octameric stoichiometry for SUR1/TRPM4 channels (Fig. 3C) .
Ca
2+ -ATPase interaction with Orai1
The secretory pathway Ca 2+ -ATPase isoform 2 (SPCA2, encoded by ATP2C2) is a Golgi-localized Ptype calcium ion transporter that has the capacity, as with other ATPases, to catalyze the hydrolysis of ATP into ADP and a free phosphate ion. In the case of SPCA2, this energy is used to power uphill transport of Ca 2+ to prime the secretory pathway (Golgi and post-Golgi vesicles). SPCA2 was found to form physical complexes with Orai1, a Ca 2+ channel better known for its role in the plasma membrane mediating store-operated Ca 2+ influx by communicating with the ER-localized STIM1 protein, which senses ER Ca 2+ depletion [169] . In contrast, Orai1-SPCA2 complexes mediate Ca 2+ signaling without STIM1 binding, and are thought to operate store-independently.
The SPCA2-Orai1 complexes influence Ca 2+ regulation and tumorigenicity in human mammary epithelium [170] . SPCA2 acts in this context as an ion [191] in place of mammalian SLC26A transporters (e.g., prestin, pendrin), the rat prestin STAS domain [192, 193] known to interact with CFTR, and human CFTR [153] . CAP70 (a PDZ-domain containing scaffolding protein) is shown to mediate the interaction. TMD, transmembrane domain; NBD, nucleotide-binding domain. (B) Mouse/Syrian hamster Kir6.2-SUR1, for which the complex structure has been solved by cryo-EM [194] ; and polycystin-2 (TRPP2) [195] [196] and rabbit SERCA (Sarco/Endoplasmic Reticulum Ca 2+ -ATPase) [197] in placeof SPCA2 (Secretory Pathway Ca 2+ -ATPase 2).
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FEBS Letters 591 (2017) 2556-2576 ª 2017 Federation of European Biochemical Societies channel chaperone and store-independent activator of Orai1, via a C-terminal domain on the transporter [170] . This control of Orai1 activity by the SPCA2 C terminus is regulated by the SPCA2 N terminus. In addition, the SPCA2 N terminus is also important for SPCA2 Ca 2+ transport activity [170] [171] [172] [173] . Interestingly, a prior study had shown that a 20 kDa C-terminal fragment of SPCA2 is expressed by a short transcript, under the control of the MIST1 transcription factor, in pancreatic acinar cells and various glandular tissues. Germline deletion of MIST1 in mice eliminated the short transcript and also disrupted Ca 2+ signaling [174] , shown subsequently to be because of the ability of the C-terminal SPCA2 fragment to regulate Orai1. There is debate about exactly how SPCA2 and Orai1 work together to mediate store-independent Ca 2+ entry, but one hypothesis is that SPCA2 positioned in membranes of the secretory pathway physically and functionally interacts with plasma membrane Orai1 to promote Ca 2+ influx through both proteins, from the extracellular side into the secretory vesicles and/or Golgi [173] (Fig. 3D ).
Amino acid transporter (SLC6A11 and SLC1A2) interactions with ion and water channels
MaxiK-GAT3
Although no functional effects have yet been reported for this interaction, a recent proteomic study uncovered complex formation between MaxiK (a.k.a. BK or Slo1, a Ca 2+ -activated K + channel), and GAT3, an electrogenic sodium-dependent gamma-aminobutyric acid (GABA) transporter encoded by SLC6A11 in mouse brain. GAT3 probably transports two Na + , one GABA, and one Cl À per transport cycle, although the Cl-transport is under debate [175] (Fig. 4A) . Subsequent coimmunoprecipitation and colocalization studies using heterologous coexpression in human embryonic kidney (HEK) 293 cells supported the proteomic findings [176] . It will be fascinating to evaluate whether there are functional consequences of this interaction, which potentially has implications for regulation of neuronal excitability.
Aqp4-eaat2
Deficiency in the water channel aquaporin 4 (AQP4) has long been known to downregulate glutamate uptake and expression of the sodium-dependent glutamate transporter, EAAT2 (Excitatory Amino Acid Transporter 2; also known as GLT-1, encoded by SLC1A2). This relationship is relatively specific as EAAT1 (GLAST, the sodium-dependent glutamate aspartate transporter, encoded by SLC1A3) was reportedly not affected by AQP4 deficiency [177] . Very recently, AQP4 was found to form a tripartite physical complex with EAAT2 and the l-opioid receptor in astrocytes (Fig. 4B) . The coassembly between AQP4 and EAAT2 is mediated by a region within amino acids 252-323 of the AQP4 C terminus. Interestingly, Fig. 4 . Amino acid transporter interactions with ion and water channels. Highresolution structures obtained by X-ray crystallography or cryo-EM are shown for proteins known to participate in chansporter complexes, or structures of their closest relatives for which highresolution structural information is available. Red arrows indicate known or putative ('?') direct physical interaction. Green lines approximate membrane boundaries. (A) Aplysia Slo1 channel [198, 199] and the SERT human serotonin receptor (SLC6A4) [200] in place of GAT3 (SLC6A11). (B) Human AQP4 [201] , human EAAT1 [202] in place of EAAT2 (EAAT1 does not bind to AQP4), and mouse lopioid receptor [203] .
morphine was found to regulate expression of the complex via activation of protein kinase C, and it is suggested that the complex might play a role in morphine dependence [178] . In another recent study, the astrocytic Fc receptor was found to be required for autoantibody-induced internalization of AQP4 and EAAT2, a finding which may aid development of therapies to treat neuromyelitis optica, an autoimmune disease in which AQP4 autoantibodies cause CNS immunopathology and secondary CNS demyelination [179] . The findings of these two studies together with others described above underline the potential importance of chansporter complexes and their disruption to human disease processes.
Sodium chloride symporter (SLC12A3) interaction with ENaC
The sodium chloride symporter, NCC (encoded by SLC12A3) is another secondary active transporter, which uses the sodium ion gradient across the apical membrane of distal convoluted tubule cells to electroneutrally transport sodium and chloride ions into the cells from tubular fluid [180] . NCC forms physical complexes in distal convoluted tubule cells with ENaC, an epithelial sodium channel that also brings Na + into distal convoluted tubule cells, by diffusion down an electrochemical gradient [181] . NCC and ENaC reciprocally regulate one another, and blocking NCC using thiazide also impairs co-expressed ENaC function, by reducing its open probability [182] .
Conclusions and Perspectives
New chansporter complexes are being discovered at an increasing rate. Chansporter complexes appear to represent a novel paradigm in cell signaling, facilitating crosstalk between channels and transporters and their responses to voltage, membrane lipids, osmolarity, and various ions and other solutes. In some cases, the 'transporter' lacks the capacity to transport, (e.g., SUR1); in other cases small fragments of the transporter can achieve regulatory effects upon the channel in the absence of the rest of the transporter (e.g., SPCA2). Outstanding questions include the stoichiometry and specific interaction interfaces of chansporter complexes, which are mostly unknown, and how widely these complexes are in utilized in mammalian cell signaling. For instance, do the majority of channels or transporters participate in these types of complexes? Also, what were the primary evolutionary driving forces that favored selection of the ability to form specific chansporter complexes? The answers will differ depending on the specific complex but there may be patterns or family-specific generalities regarding which specific evolutionary advantages might be conferred by formation of each of the various chansporter complexes. Several hypotheses are given below.
(i) Nanodomains. Chansporter complexes may act in nanodomains that exist to reduce spatiotemporal barriers between different signaling mechanisms. Diffusion of substrates imported by the transporters may be important in some cases for regulating coassembled channel function. In these instances, it may be advantageous to position specific chansporter pairs close to one another. In the case of myo-inositol transporters such as SMIT1, for example, the myo-inositol they bring in is converted to PIP 2 , which happens to be a potent regulator of channels that form complexes with SMIT1. Because PIP 2 diffusion within the membrane is quite slow, KCNQ-SMIT proximity could help ensure locally high PIP 2 concentrations for activation of KCNQ channels. This may be especially important in constrained spaces such as axons [130] . (ii) Biosensor sharing. Channels and transporters might coassemble because it is advantageous to exploit one another's biosensory capabilities. This is particularly obvious in the cases where one of the partners has lost its transport capabilities. In the case of K ATP channels, although SURs do not possess transport machinery, they sense the metabolic state of the cell and report this to the Kir6 channels to regulate their function [166] . Likewise, cupcake may not possess sugar transport capabilities, but it is suggested to sense sugar levels [136, 137] and it is possible that via coassembly, it can communicate these to dKCNQ to regulate feeding behavior.
KCNQ1 is adept at sensing its immediate environment, and it is possible that by responding to this in the form of altered channel activity and/or conformation, it may be able to regulate coassembled SMIT activity and thus act as a biosensor for its transporter partner. KCNQ1 requires bound calmodulin for channel trafficking and function. One possibility is that Ca 2+ binding to KCNQ1-bound calmodulin exerts conformational effects that can be transmitted to coassembled SMITs to Ca 2+ -dependently regulate myo-inositol intake. KCNQs, and all other voltagegated ion channels, sense membrane potential via their VSDs. Thus, KCNQs can communicate information about the membrane potential of the cell to SMIT1 via either S4 position or channel activity, or perhaps both. Thus, we found that KCNQ2/3 coexpression enabled SMIT1 to maintain its transport activity during cellular depolarization, whereas without KCNQ2/ 3, cellular depolarization lowered SMIT1 transport activity [130] . In contrast, locking the KCNQ1 S4 open (to mimic aspects of cell depolarization without actually depolarizing the cell) inhibited activity of coexpressed SMIT1 [110] . In addition, the sensitivity of KCNQ1 to extracellular pH (pH o ) is modulated by coexpressed KCNEs. For example, homomeric KCNQ1 is inhibited by low pH o , whereas KCNQ1-KCNE2 activity is potentiated by low pH o [43] . It is possible, then, that depending on the coassembled KCNE subunit, KCNQ1 could transmit information about extracellular pH to SMITs or other coassembled transporters to regulate their activity.
(iii) Feedback. As described above, KCNQ1 activity is sensitive to PIP 2 concentration, and may therefore communicate information about myo-inositol-derived PIP 2 levels to bound SMITs to regulate their myo-insoitol uptake activity. This could be important in certain circumstances, for example, if a strong downhill Na + gradient was favoring excessive myo-inositol uptake but local PIP 2 levels were already inappropriately high. Coassembly with different KCNEs can change the PIP 2 sensitivity of KCNQ1, the established example being that KCNE1 increases PIP 2 sensitivity 100-fold compared to KCNQ1 alone [71] . Thus, cells may be able to tune how KCNQ1 controls SMIT activity by differentially expressing the various KCNEs. (iv) Tuning of channel properties. We recently found that SMIT1 can alter the ion selectivity, gating kinetics, and pharmacology of coexpressed KCNQs, via direct interaction with the pore module [114] . This is good evidence of close physical interaction, but some of these modifications may also serve a physiological role. We found that SMIT1 increased KCNQ Na + permeability, which could alter action potential morphology or tune the resting membrane potential in the cells where these complexes occur. Interestingly, SMIT1 coassembly increases KCNQ2/3 Cs + permeability, potentially resolving a long-standing discrepancy between the relative permeability for Cs + of cloned KCNQ2/3 versus native M current generated by this channel [114] . In addition, modification of KCNQ gating kinetics by SMIT1, which in the case of KCNQ1 was KCNE1 dependent, could also modify action potential morphology. We do not yet know whether addition of substrate changes the effects of SMIT1 on KCNQ channel properties, but this could add another dynamic mode of regulation or feedback. (v)Location and surface stability. Finally, membrane proteins each contain within their primary sequences information that determines how, when and where they traffic to the cell surface, how long they remain there, and what is their fate once they are recycled from the plasma membrane. When one or more different membrane proteins coassemble, they can thus influence one another's fate. In K ATP channels, for example, Kir6 and SUR subunits contain ER retention motifs that dictate they can only reach the surface if coassembled [183, 184] . For other chansporter complexes, the effects may be more subtle, but if complexes form early in biogenesis, could ensure that a specific channel only traffics to a particular axonal region or side of a polarized cell, when a specific transporter partner coassembles with it. KCNEs can also dictate Kv a subunit subcellular localization, subunit composition, and endocytosis rate, and therefore could also dictate these same properties for specific chansporter complexes if the channel were the dominant partner in this respect. In this model, expression by the cell of specific channel subunit combinations could ensure that a partnered transporter reached the appropriate part of a cell to fulfill a specific task, in a specific manner dictated by the channel, and could also regulate how long the transporter remained in that location. Of course, the reciprocal is equally likely to be the case.
High-resolution structures are now available for either the proteins, or their close surrogates, within many of the known chansporter complexes (Figs 1-4) . Thus, future in silico modeling guided by site-directed mutagenesis and functional assays, and vice-versa, may help elucidate how chansporter complexes fit together, how the partners regulate one another, and the reasons why complex formation offers an advantage over more conventional, long-range signaling. 
